# Locus Biosciences

CDMO services — Scalable GMP manufacturing.

Source: https://en.bioecon.ru/companies/locus-biosciences/
Updated: 2026-07-02

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Total funding ranges from $136.23M to $165.4M | https://prospeo.io/c/locus-biosciences-revenue |
| Capacity | Millions of doses annually, up to 200 L scale per phage | https://www.locus-bio.com/guardian/ |
| Certification | 2021 ISPE Facility of the Year Award (Honorable Mention) | https://www.ipsdb.com/projects/cgmp-crispr-facility, https://www.locus-bio.com/locus-biomanufacturing-solutions-facility/ |
| Regulatory approval | Compliant with US (FDA) and international standards (EMA, PMDA) | https://www.ipsdb.com/projects/cgmp-crispr-facility, https://www.locus-bio.com/locus-biomanufacturing-solutions-facility/ |
| Production site | 12,000 sq. ft. cGMP facility in Morrisville, North Carolina | https://bekbg.com/projects/locus-biosciences/, https://www.ipsdb.com/projects/cgmp-crispr-facility, https://www.locus-bio.com/guardian/, https://www.locus-bio.com/locus-biomanufacturing-solutions-facility/ |
| Headcount | 55-61 employees as of 2026 [medium confidence] | https://prospeo.io/c/locus-biosciences-revenue |
| Revenue | Estimated annual revenue ranges from $3M to $15.9M [medium confidence] | https://prospeo.io/c/locus-biosciences-revenue |

Independent sources: bekbg.com, ipsdb.com, locus-bio.com, prospeo.io

## Technologies

- [Bacteriophage therapy](https://en.bioecon.ru/technology/bacteriophage-therapy/)